1wum
From Proteopedia
| Line 5: | Line 5: | ||
|SITE= | |SITE= | ||
|LIGAND= <scene name='pdbligand=NP2:N-(3-AMINOPROPYL)-2-NITROBENZENAMINE'>NP2</scene> | |LIGAND= <scene name='pdbligand=NP2:N-(3-AMINOPROPYL)-2-NITROBENZENAMINE'>NP2</scene> | ||
| - | |ACTIVITY= [http://en.wikipedia.org/wiki/Histone_acetyltransferase Histone acetyltransferase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.3.1.48 2.3.1.48] | + | |ACTIVITY= <span class='plainlinks'>[http://en.wikipedia.org/wiki/Histone_acetyltransferase Histone acetyltransferase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.3.1.48 2.3.1.48] </span> |
|GENE= | |GENE= | ||
| + | |DOMAIN= | ||
| + | |RELATEDENTRY=[[1b91|1b91]], [[1jm4|1JM4]], [[1wug|1WUG]] | ||
| + | |RESOURCES=<span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1wum FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1wum OCA], [http://www.ebi.ac.uk/pdbsum/1wum PDBsum], [http://www.rcsb.org/pdb/explore.do?structureId=1wum RCSB]</span> | ||
}} | }} | ||
| Line 31: | Line 34: | ||
[[Category: Zeng, L.]] | [[Category: Zeng, L.]] | ||
[[Category: Zhou, M M.]] | [[Category: Zhou, M M.]] | ||
| - | [[Category: NP2]] | ||
[[Category: bromodomain]] | [[Category: bromodomain]] | ||
[[Category: chemical ligand]] | [[Category: chemical ligand]] | ||
| Line 39: | Line 41: | ||
[[Category: np2]] | [[Category: np2]] | ||
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Mar 31 00:41:15 2008'' |
Revision as of 21:41, 30 March 2008
| |||||||
| Ligands: | |||||||
| Activity: | Histone acetyltransferase, with EC number 2.3.1.48 | ||||||
| Related: | 1b91, 1JM4, 1WUG
| ||||||
| Resources: | FirstGlance, OCA, PDBsum, RCSB | ||||||
| Coordinates: | save as pdb, mmCIF, xml | ||||||
Complex structure of PCAF bromodomain with small chemical ligand NP2
Overview
Development of drug resistance from mutations in the targeted viral proteins leads to continuation of viral production by chronically infected cells, contributing to HIV-mediated immune dysfunction. Targeting a host cell protein essential for viral reproduction, rather than a viral protein, may minimize the viral drug resistance problem as observed with HIV protease inhibitors. We report here the development of a novel class of N1-aryl-propane-1,3-diamine compounds using a structure-based approach that selectively inhibit the activity of the bromodomain of the human transcriptional co-activator PCAF, of which association with the HIV trans-activator Tat is essential for transcription and replication of the integrated HIV provirus.
About this Structure
1WUM is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
Selective small molecules blocking HIV-1 Tat and coactivator PCAF association., Zeng L, Li J, Muller M, Yan S, Mujtaba S, Pan C, Wang Z, Zhou MM, J Am Chem Soc. 2005 Mar 2;127(8):2376-7. PMID:15724976
Page seeded by OCA on Mon Mar 31 00:41:15 2008
Categories: Histone acetyltransferase | Homo sapiens | Single protein | Li, J. | Mujtaba, S. | Muller, M. | Pan, C. | Wang, Z. | Yan, S. | Zeng, L. | Zhou, M M. | Bromodomain | Chemical ligand | Histone-acetyltransferase | Nmr-structure | Np1 | Np2
